ARDC Research Link Australia Research Link Australia   BETA Research
Link
Australia
  • ARDC Newsletter Subscribe
  • Contact Us
  • Home
  • About
  • Feedback
  • Explore Collaborations
  • Researcher
  • Funded Activity
  • Organisation
  • Researcher
  • Funded Activity
  • Organisation
  • Researcher
  • Funded Activity
  • Organisation

Need help searching? View our Search Guide.

Advanced Search

Current Selection
Research Topic : VIRAL INFECTION
Field of Research : Clinical chemistry (incl. diagnostics)
Clear All
Filter by Field of Research
Clinical chemistry (incl. diagnostics) (38)
Filter by Socio-Economic Objective
Search did not return any results.
Filter by Funding Provider
National Health and Medical Research Council (38)
Filter by Status
Closed (38)
Filter by Scheme
NHMRC Project Grants (22)
Early Career Fellowships (6)
NHMRC Postgraduate Scholarships (4)
NHMRC Research Fellowships (2)
Programs (2)
Career Development Fellowships (1)
Research Fellowships (1)
Filter by Country
Australia (1)
Filter by Australian State/Territory
SA (1)
  • Researchers (0)
  • Funded Activities (38)
  • Organisations (0)
  • Funded Activity

    Study Of CD4+ T Cell Response To Cytomegalovirus

    Funder
    National Health and Medical Research Council
    Funding Amount
    $314,821.00
    More information
    Funded Activity

    Investigation Of The Signal(s) Involved In The Selection Of Memory T Cells From The Effector CD8+T Cell Pool Following..

    Funder
    National Health and Medical Research Council
    Funding Amount
    $216,129.00
    More information
    Funded Activity

    Molecular Basis Of T Cell Receptor Bias In Viral Immunity

    Funder
    National Health and Medical Research Council
    Funding Amount
    $540,075.00
    Summary
    Viral infection results in the activation and proliferation of T cells that eradicate infected cells. Recognition of infected cells is meditated by presentation and recognition of viral protein fragments via specific cell surface receptors. This proposal plans to examine the factors that determine the diversity of the immune response and the consequences of such diversity on anti-viral immunity. This has implications for the development of vaccines.
    More information
    Funded Activity

    Understanding And Controlling Influenza

    Funder
    National Health and Medical Research Council
    Funding Amount
    $11,182,093.00
    Summary
    While current influenza vaccines blunt winter epidemics, they must be updated frequently to keep up with virus mutation and they do not protect against pandemics caused by new flu viruses (such as bird flu). This program will define how flu virus interacts with the immune system to generate immunity mediated particularly by “killer” T cells. We will use this knowledge to develop and evaluate vaccines that induce long-lasting T-cell immunity that can protect against both seasonal and pandemic flu .... While current influenza vaccines blunt winter epidemics, they must be updated frequently to keep up with virus mutation and they do not protect against pandemics caused by new flu viruses (such as bird flu). This program will define how flu virus interacts with the immune system to generate immunity mediated particularly by “killer” T cells. We will use this knowledge to develop and evaluate vaccines that induce long-lasting T-cell immunity that can protect against both seasonal and pandemic flu.
    Read more Read less
    More information
    Funded Activity

    Long-lived CD8 T Cell Responses Induced By A Recombinant Cytomegalovirus Vector

    Funder
    National Health and Medical Research Council
    Funding Amount
    $234,750.00
    Summary
    The priming of the immune system to protect against infection and disease is an important means to alleviate these conditions. Current vaccination technologies often rely on multiple inoculations (prime-boosting). In addition, specific priming of the immune system against pathogens that target mucosal sites has been difficult and often lacks efficacy resulting in temporary or variable protection. Using a well developed mouse model for a common human virus, we have explored the potential of this .... The priming of the immune system to protect against infection and disease is an important means to alleviate these conditions. Current vaccination technologies often rely on multiple inoculations (prime-boosting). In addition, specific priming of the immune system against pathogens that target mucosal sites has been difficult and often lacks efficacy resulting in temporary or variable protection. Using a well developed mouse model for a common human virus, we have explored the potential of this agent as a vaccine agent, making use of its long term persistence in the infected host to provide continued antigenic stimulation of the immune system. We have found that very strong and long lasting responses can be elicited after a single inoculation of avirulent virus. In this study, this effect will be further explored and developed.
    Read more Read less
    More information
    Funded Activity

    Cytolytic Mechanisms Required For Virus Elimination.

    Funder
    National Health and Medical Research Council
    Funding Amount
    $698,567.00
    Summary
    Viruses provoke devastating disease. The immune system kills cells that are infected with viruses. To do this, immune cells release granules that are packaged with different killer molecules. It is unknown which killer molecules participate over the course of an immune response to virus. Here, we will investigate this process for cells that are infected with influenza A virus and herpes simplex virus. This study will allow the design of strategies to limit widespread damage inflicted by viruses.
    More information
    Funded Activity

    Interplay Of Innate And Adaptive Immunity To Influenza A Virus

    Funder
    National Health and Medical Research Council
    Funding Amount
    $555,693.00
    Summary
    Influenza is an acute febrile respiratory illness caused by influenza virus infection, and may trigger potentially life-threatening complications especially in the young and elderly. Immunity against influenza virus involves integration of the innate and adaptive immune system. We will use cutting-edge 2-photon microscopy to determine the orchestration of innate and adaptive immune cell interactions during viral infection. Results may provide for enhanced therapeutic or protective measures.
    More information
    Funded Activity

    Dissecting Mechanisms Of Generalised Immune Activation And Cellular Dysfunction In HIV Infection

    Funder
    National Health and Medical Research Council
    Funding Amount
    $422,576.00
    Summary
    How HIV infection compromises the host immune system is still not well understood. We will study how HIV surface proteins contribute to heightened immune activation during chronic infection. This generalised activation eventually leads to dysfunctional cellular immune responses and loss of partial control of infection. We will additionally investigate the extent and impact of the loss of functional immune responses in chronic HIV infection.
    More information
    Funded Activity

    Tapasin And Major Histocompatibility Complex Class I Antigen Presentation

    Funder
    National Health and Medical Research Council
    Funding Amount
    $226,650.00
    Summary
    An effective T cell response (cellular immune response) to infections is vital to a functional immune system. Normally, proteins are cleaved into small molecules called peptides and these peptides are in turn presented by Major Histocompatibility Complex molecules to T cells. However, we have only partial understanding of what determines the choice of peptides that are finally presented to T cells. Recent research suggests that a molecule called tapasin may also influence the choice of peptides. .... An effective T cell response (cellular immune response) to infections is vital to a functional immune system. Normally, proteins are cleaved into small molecules called peptides and these peptides are in turn presented by Major Histocompatibility Complex molecules to T cells. However, we have only partial understanding of what determines the choice of peptides that are finally presented to T cells. Recent research suggests that a molecule called tapasin may also influence the choice of peptides. This research proposal aims to examine the role of tapasin in this regard. A thorough understanding of the basic principles of peptide presentation to T cells is crucial to the design of effective vaccines. Furthermore it will also broaden our understanding of immunological responses to cancer, autoimmune diseases and infections.
    Read more Read less
    More information
    Funded Activity

    Viral Reservoirs:Role Of Naive T-cells In The Pathogeneisis Of T-cell Decline And Longterm Persistence Of HIV Infection.

    Funder
    National Health and Medical Research Council
    Funding Amount
    $85,716.00
    Summary
    Despite dramatic advances in treatment for HIV infection, HIV cannot be cured. The main reason why cure is not possible is because HIV can persist in long lived cells and these infected cells are not recognised by the immune system. This project will examine the role of a particular type of infection fighting cell, the naive T-cell, in long term persistence of HIV. The project will determine how naive T-cells are infected with HIV and what happens to these cells following HIV treatment.
    More information

    Showing 1-10 of 38 Funded Activites

    • 1
    • 2
    • 3
    Advanced Search

    Advanced search on the Researcher index.

    Advanced search on the Funded Activity index.

    Advanced search on the Organisation index.

    National Collaborative Research Infrastructure Strategy

    The Australian Research Data Commons is enabled by NCRIS.

    ARDC CONNECT NEWSLETTER

    Subscribe to the ARDC Connect Newsletter to keep up-to-date with the latest digital research news, events, resources, career opportunities and more.

    Subscribe

    Quick Links

    • Home
    • About Research Link Australia
    • Product Roadmap
    • Documentation
    • Disclaimer
    • Contact ARDC

    We acknowledge and celebrate the First Australians on whose traditional lands we live and work, and we pay our respects to Elders past, present and emerging.

    Copyright © ARDC. ACN 633 798 857 Terms and Conditions Privacy Policy Accessibility Statement
    Top
    Quick Feedback